UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 2, 2017

ALTERYX, INC.

(Exact Name of the Registrant as Specified in Charter)

(888) 836-4274

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 2, 2017, the Board of Directors (the “Board”) of Alteryx, Inc., a Delaware corporation (the “Company”), appointed Eileen Schloss to serve as a director of the Company, effective May 2, 2017. Ms. Schloss will serve as a Class I director whose term will expire at the Company’s 2018 annual meeting of stockholders. The Board also appointed Ms. Schloss to serve as a member of the Compensation Committee of the Board of Directors.

There is no arrangement or understanding between Ms. Schloss and any other persons pursuant to which she was selected as a director. Ms. Schloss has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Ms. Schloss will receive the same compensation as the Company’s other non-employee directors as described in the Company’s final prospectus filed with the Securities and Exchange Commission (the “SEC”) on March 24, 2017 in connection with the Company’s initial public offering pursuant to Rule 424(b) under the Securities Act of 1933, as amended.

Ms. Schloss has also entered into the Company’s standard form of indemnity agreement, which is attached as Exhibit 10.1 to the Company’s Registration Statement on Form S-1 filed with the SEC on February 24, 2017 (File No. 333-216237).

A copy of the Company’s press release relating to this announcement is being furnished as Exhibit 99.1 to this Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.